These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 26539578)

  • 21. Alcoholism in the elderly.
    Rigler SK
    Am Fam Physician; 2000 Mar; 61(6):1710-6, 1883-4, 1887-8 passim. PubMed ID: 10750878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alcohol dependence: the impact of cognitive behaviour therapy with or without naltrexone on subjective health status.
    Feeney GF; Connor JP; Young RM; Tucker J; McPherson A
    Aust N Z J Psychiatry; 2004 Oct; 38(10):842-8. PubMed ID: 15369544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Screening, Brief Intervention, Referral to Treatment(SBIRT) model for alcohol use disorder in Japan].
    Isono H; Yoshimoto H
    Nihon Rinsho; 2015 Sep; 73(9):1528-35. PubMed ID: 26394516
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The 5-item Alcohol Use Disorders Identification Test (AUDIT-5): an effective brief screening test for problem drinking, alcohol use disorders and alcohol dependence.
    Kim JW; Lee BC; Lee DY; Seo CH; Kim S; Kang TC; Choi IG
    Alcohol Alcohol; 2013; 48(1):68-73. PubMed ID: 22917753
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention, screening, and treatment for heavy drinking and alcohol use disorder.
    Knox J; Hasin DS; Larson FRR; Kranzler HR
    Lancet Psychiatry; 2019 Dec; 6(12):1054-1067. PubMed ID: 31630982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sodium oxybate plus nalmefene for the treatment of alcohol use disorder: A case series.
    Caputo F; Maremmani AG; Addolorato G; Domenicali M; Zoli G; D'Amore A; Maremmani I; Bernardi M
    J Psychopharmacol; 2016 Apr; 30(4):402-9. PubMed ID: 26860331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alcohol Use Disorders in Primary Health Care: What Do We Know and Where Do We Go?
    Rehm J; Anderson P; Manthey J; Shield KD; Struzzo P; Wojnar M; Gual A
    Alcohol Alcohol; 2016 Jul; 51(4):422-7. PubMed ID: 26574600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent Developments in Pharmacotherapy of Alcoholism.
    Soyka M; Lieb M
    Pharmacopsychiatry; 2015 Jul; 48(4-5):123-35. PubMed ID: 25761458
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Addiction disorders.
    Merrill JO; Duncan MH
    Med Clin North Am; 2014 Sep; 98(5):1097-122. PubMed ID: 25134875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Naltrexone and disulfiram in patients with alcohol dependence and current depression.
    Petrakis I; Ralevski E; Nich C; Levinson C; Carroll K; Poling J; Rounsaville B;
    J Clin Psychopharmacol; 2007 Apr; 27(2):160-5. PubMed ID: 17414239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Naltrexone and acamprosate. Using new drugs for alcohol dependence.
    Tedeschi M
    Aust Fam Physician; 2001 May; 30(5):447-50. PubMed ID: 11432017
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis.
    O'Malley SS; Krishnan-Sarin S; Farren C; Sinha R; Kreek MJ
    Psychopharmacology (Berl); 2002 Feb; 160(1):19-29. PubMed ID: 11862370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancing access to alcohol use disorder pharmacotherapy and treatment in primary care settings: ADaPT-PC.
    Hagedorn HJ; Brown R; Dawes M; Dieperink E; Myrick DH; Oliva EM; Wagner TH; Wisdom JP; Harris AH
    Implement Sci; 2016 May; 11():64. PubMed ID: 27164835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial.
    Garbutt JC; Kranzler HR; O'Malley SS; Gastfriend DR; Pettinati HM; Silverman BL; Loewy JW; Ehrich EW;
    JAMA; 2005 Apr; 293(13):1617-25. PubMed ID: 15811981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Feasibility of screening and intervention for alcohol problems among young adults in the ED.
    Hungerford DW; Williams JM; Furbee PM; Manley WG; Helmkamp JC; Horn K; Pollock DA
    Am J Emerg Med; 2003 Jan; 21(1):14-22. PubMed ID: 12563573
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Naltrexone in patients with bipolar disorder and alcohol dependence.
    Brown ES; Beard L; Dobbs L; Rush AJ
    Depress Anxiety; 2006; 23(8):492-5. PubMed ID: 16841344
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Naltrexone in the treatment of alcohol dependence: what clinicians need to know.
    Drummond C
    Addiction; 2001 Dec; 96(12):1857-9. PubMed ID: 11791527
    [No Abstract]   [Full Text] [Related]  

  • 38. Naltrexone and disulfiram in patients with alcohol dependence and comorbid psychiatric disorders.
    Petrakis IL; Poling J; Levinson C; Nich C; Carroll K; Rounsaville B;
    Biol Psychiatry; 2005 May; 57(10):1128-37. PubMed ID: 15866552
    [TBL] [Abstract][Full Text] [Related]  

  • 39. German Guidelines on Screening, Diagnosis and Treatment of Alcohol Use Disorders.
    Mann K; Batra A; Fauth-Bühler M; Hoch E;
    Eur Addict Res; 2017; 23(1):45-60. PubMed ID: 28178695
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Interactions between naltrexone, an opioid antagonist, and opioids administered during general anesthesia].
    Tesson B; Bigot-Viale A; Vigue JP; Pierrot M; Granry JC
    Ann Fr Anesth Reanim; 1999 Feb; 18(2):230-2. PubMed ID: 10207596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.